Skip to content

Effectiveness of Oleanolic Acid as Intracanal Medicament on Infectious/Inflammatory Contents in Teeth With Apical Periodontitis

Effectiveness of Oleanolic Acid as Intracanal Medicament on Infectious/Inflammatory Contents in Teeth With Apical Periodontitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07534943
Enrollment
36
Registered
2026-04-16
Start date
2026-03-01
Completion date
2026-06-01
Last updated
2026-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endodotic Microbiota, Inflammatory Cytokines, Intracanal Medicaments

Keywords

Intracanal medicaments, Endodontic infections, Inflammatory cytokines

Brief summary

The objective of this study is to investigate "clinically" the effectiveness of Oleanolic acid based intracanal medicament compared to the commonly used intracanal medicaments (Calcium hydroxide and Ledermix) on the levels of bacteria in root canals and inflammatory cytokines in the periradicular tissues of teeth with apical periodontitis.

Interventions

PROCEDURERoot canal treatment

Root canal treatments with administration of intracanal medicaments

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

1. Single rooted teeth with pulp necrosis and apical periodontitis. 2. The age ranges from 20 to 60 years.

Exclusion criteria

1. Patient receiving antibiotic treatment within the preceding 3 months. 2. Patient reporting systemic disease. 3. Teeth that can not be isolated with rubber dam. 4. Teeth with periodontal pockets deeper than 3 mm.

Design outcomes

Primary

MeasureTime frameDescription
Relief of signs and symptoms of apical periodontitis1 WeekAbsence of discomfort with percussion, Absence of inflammatory exudate from the root canal.
Decrease in bacterial count within the root canal.1 weekA sample will be taken from the canal to assess the decrease in bacterial count inside the root canal by the effect of intracanal medicament.
Decrease in interleukin TNF-alpha, IL-1 Beta and PG-E2 in the periapical tissues1 weekA sample will be taken from the periapical region to detect the effect of the intracanal medicaments in reducing inflammation and promoting healing in the periapical region.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 17, 2026